Prostaglandin E2 up-regulates macrophage-derived chemokine production but suppresses IFN-Inducible protein-10 production by APC

被引:66
作者
Kuroda, E [1 ]
Sugiura, T [1 ]
Okada, K [1 ]
Zeki, K [1 ]
Yamashita, U [1 ]
机构
[1] Univ Occupat & Environm Hlth, Sch Med, Dept Immunol, Yahatanishi Ku, Kitakyushu, Fukuoka 8078555, Japan
关键词
D O I
10.4049/jimmunol.166.3.1650
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
PGE(2) has been known to suppress Th1 responses. We studied the role of PGE(2) in two representative chemokines, macrophage-derived chemokine (MDC) and IFN-inducible protein-10, production by LPS- or CD40-stimulated spleen cells. The production of MDC, one of the ligands for CCR4 preferentially expressed on Th2, was enhanced in nonstimulated, LPS-, CD40-, or CD3-stimulated spleen cells by the pretreatment with PGE(2), while the production of IFN-inducible protein-10, a representative ligand for CXC chemokine receptor 3 expressed on Th1, was suppressed. MDC production was also enhanced by IL-4, IL-5, and intracellular cAMP-elevating agents such as dibutyryl cAMP and 3-isobutyl-1-methylxanthine, and the effect of IL-4, IL-5, and ;PGE(2) was additive. However, the pretreatment with IL-6, IL-10, or TGF-beta, or the neutralization of IFN-gamma or IL-12 had no effect on MDC production. B cells, macrophages, and dendritic cells were main producers of MDC, while T cells produced only a small amount of MDC, MDC production by B cells was equally stimulated by LPS and anti-CD40 Ab, while that by macrophages and dendritic cells was more markedly stimulated by anti-CD40 Ab, and PGE(2) further enhanced MDC production by these stimulated cells. These results indicate that PGE, regulates Th1/Th2-related chemokine production by B cells, macrophages, and dendritic cells, and that this is a new function of PGE(2) for the regulation of Th2 immune responses at the induction and activation stages.
引用
收藏
页码:1650 / 1658
页数:9
相关论文
共 56 条
  • [1] Prostaglandin E-2 and IL-4 provide naive CD4(+) T cells with distinct inhibitory signals for the priming of IFN-gamma production
    Abe, N
    Katamura, K
    Shintaku, N
    Fukui, T
    Kiyomasu, T
    Iio, J
    Ueno, H
    Tai, GX
    Mayumi, M
    Furusho, K
    [J]. CELLULAR IMMUNOLOGY, 1997, 181 (01) : 86 - 92
  • [2] Andrew DP, 1998, J IMMUNOL, V161, P5027
  • [3] Effect of PDE4 inhibitors on zymosan-induced IL-8 release from human neutrophils: Synergism with prostanoids and salbutamol
    Au, BT
    Teixeira, MM
    Collins, PD
    Williams, TJ
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 1998, 123 (06) : 1260 - 1266
  • [4] CCR5+ and CXCR3+ T cells are increased in multiple sclerosis and their ligands MIP-1α and IP-10 are expressed in demyelinating brain lesions
    Balashov, KE
    Rottman, JB
    Weiner, HL
    Hancock, WW
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (12) : 6873 - 6878
  • [5] Differential expression of chemokine receptors and chemotactic responsiveness of type 1 T helper cells (Th1s) and Th2s
    Bonecchi, R
    Bianchi, G
    Bordignon, PP
    D'Ambrosio, D
    Lang, R
    Borsatti, A
    Sozzani, S
    Allavena, P
    Gray, PA
    Mantovani, A
    Sinigaglia, F
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1998, 187 (01) : 129 - 134
  • [6] Divergent effects of interleukin-4 and interferon-γ on macrophage-derived chemokine Production:: An amplification circuit of polarized T helper 2 responses
    Bonecchi, R
    Sozzani, S
    Stine, JT
    Luini, W
    D'Amico, G
    Allavena, P
    Chantry, D
    Mantovani, A
    [J]. BLOOD, 1998, 92 (08) : 2668 - 2671
  • [7] IP-10 mRNA expression in cultured keratinocytes is suppressed by inhibition of protein kinase-C and tyrosine kinase and elevation of cAMP
    Boorsma, DM
    Flier, J
    van den Brink, EN
    Sampat, S
    Walg, HL
    Willemze, R
    Tensen, CP
    Stoof, TJ
    [J]. CYTOKINE, 1999, 11 (07) : 469 - 475
  • [8] CHAN SC, 1993, J IMMUNOL, V151, P3345
  • [9] Induction of TH1 and TH2 CD4+ T cell responses: The alternative approaches
    Constant, SL
    Bottomly, K
    [J]. ANNUAL REVIEW OF IMMUNOLOGY, 1997, 15 : 297 - 322
  • [10] DEKRUYFF RH, 1992, J IMMUNOL, V149, P3468